JPRN-UMIN000009536招募中1 期
Phase 1 study of Gemcitabine, Cisplatin and S-1 combination chemotherapy in patients with advanced biliary tract cancer - Phase 1 study of Gemcitabine, Cisplatin and S-1 combination chemotherapy in patients with advanced biliary tract cancer
Kitasato University School of Medicine Department of Gastroenterology Medicine0 个研究点目标入组 12 人开始时间: 2012年12月13日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Simultaneous or metachronous double cancers. 2)Severe complications. 3)The case suspected of infection with feaver. 4)A history of motor paralysis or peripheral neuropathy or edema. 5)Pleural or cardiac effusion requiring treatment. 6)Massive abdominal effusion. 7)Pregnancy or the desire to preserve fecundity. 8)Active lung disease such as interstitial pneumonia or pulmonary fibrosis. 9)Mental disease or psychotic manifestation. 10) A history of serious drug allergy. 11)A history of sever allergic reaction with gemcitabine or cisplatin or S-1. 12)Being treated with other pyrimidine fluoride antineoplastic agents. 13)Being treated with flucytosine. 14)Any patients judged by the investigator to be unfit to participate in the study.
研究者
相似试验
已完成
1 期
Phase I study of Gemcitabine, Cisplatin and S-1 for advanced biliary tract cancer.Biliary tract cancerJPRN-UMIN000006123Tsukuba University Hospital, Division of Gastroenterology12
已完成
1 期
Phase I/II study of gemcitabine/cisplatin/S-1(GCS) combination therapy for patients with advanced biliary tract cancerPatients with advanced biliary tract cancer that was not amenable to potentially curative surgery or that had recurred after surgeryJPRN-UMIN000004468Kansai Hepatobiliary Oncology Group55
尚未招募
Unknown
Phase III study of gemcitabine, cisplatin plus S-1 combination therapy versus gemcitabine, cisplatin plus immune checkpoint inhibitor combination therapy in advanced biliary tract cancer.advanced biliary tract cancerJPRN-UMIN000051689Yamaguchi University460
尚未招募
不适用
Phase I study of gemcitabine and carboplatin plus sorafenib in patients with advanced solid tumorsadvanced solid tumors10027655CancerNL-OMON31053Antoni van Leeuwenhoek Ziekenhuis28
招募中
2 期
A Phase II study of Gemcitabine, Cisplatin and Bevacizumab for the patients with first recurrent and refractory ovarian clear cell carcinomaJPRN-UMIN000051087Kansai Clinical Oncology Group(KCOG)28